Triple antithrombotic management after stent implantation: when and how?
Schömig
Albert
A
Deutsches Herzzentrum München and 1. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Germany. aschoemig@dhm.mhn.de
Sarafoff
Nikolaus
N
Seyfarth
Melchior
M
D001281:Atrial Fibrillation / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000209:etiology; D003328:Coronary Thrombosis / Q000188:drug therapy* / Q000601:surgery; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy; D016127:Heart Valve Prolapse; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D019934:International Normalized Ratio; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015607:Stents; D054556:Venous Thromboembolism / Q000188:drug therapy
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors